Titre : Maladies de la jonction neuromusculaire

Maladies de la jonction neuromusculaire : Questions médicales fréquentes

Termes MeSH sélectionnés :

Early Detection of Cancer
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Maladies de la jonction neuromusculaire : Questions médicales les plus fréquentes", "headline": "Maladies de la jonction neuromusculaire : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Maladies de la jonction neuromusculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-27", "dateModified": "2025-03-24", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Maladies de la jonction neuromusculaire" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Maladies neuromusculaires", "url": "https://questionsmedicales.fr/mesh/D009468", "about": { "@type": "MedicalCondition", "name": "Maladies neuromusculaires", "code": { "@type": "MedicalCode", "code": "D009468", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.668" } } }, "about": { "@type": "MedicalCondition", "name": "Maladies de la jonction neuromusculaire", "alternateName": "Neuromuscular Junction Diseases", "code": { "@type": "MedicalCode", "code": "D020511", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Rizwan Qaisar", "url": "https://questionsmedicales.fr/author/Rizwan%20Qaisar", "affiliation": { "@type": "Organization", "name": "Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates; Space Medicine Research Group, Sharjah Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates; Cardiovascular Research Group, Sharjah Institute for Medical and Health Sciences, University of Sharjah, Sharjah 27272, United Arab Emirates. Electronic address: rqaisar@sharjah.ac.ae." } }, { "@type": "Person", "name": "Asima Karim", "url": "https://questionsmedicales.fr/author/Asima%20Karim", "affiliation": { "@type": "Organization", "name": "Basic Medical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates." } }, { "@type": "Person", "name": "David Lacomis", "url": "https://questionsmedicales.fr/author/David%20Lacomis", "affiliation": { "@type": "Organization", "name": "Departments of Neurology and Pathology (Neuropathology), University of Pittsburgh School of Medicine, Pittsburgh, PA; and." } }, { "@type": "Person", "name": "Ines Boehm", "url": "https://questionsmedicales.fr/author/Ines%20Boehm", "affiliation": { "@type": "Organization", "name": "Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK." } }, { "@type": "Person", "name": "Ross A Jones", "url": "https://questionsmedicales.fr/author/Ross%20A%20Jones", "affiliation": { "@type": "Organization", "name": "Edinburgh Medical School: Biomedical Sciences, University of Edinburgh, Edinburgh, UK." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Comparison of breast fine-needle aspiration cytology and tissue sampling for high-throughput proteomic analysis and cancer biomarker detection.", "datePublished": "2024-05-30", "url": "https://questionsmedicales.fr/article/38815563", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1159/000539478" } }, { "@type": "ScholarlyArticle", "name": "The Impact of Prostate Volume on Prostate Cancer Detection: Comparing Magnetic Resonance Imaging with Transrectal Ultrasound in Biopsy-naïve Men.", "datePublished": "2024-04-22", "url": "https://questionsmedicales.fr/article/38694877", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.euros.2024.04.001" } }, { "@type": "ScholarlyArticle", "name": "Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study.", "datePublished": "2024-04-15", "url": "https://questionsmedicales.fr/article/38619974", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/03936155241244802" } }, { "@type": "ScholarlyArticle", "name": "Enhancing Colorectal Cancer Tumor Bud Detection Using Deep Learning from Routine H&E-Stained Slides.", "datePublished": "2024-04-03", "url": "https://questionsmedicales.fr/article/38752165", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1117/12.3006796" } }, { "@type": "ScholarlyArticle", "name": "Pancreatic cancer detection with dual-energy CT: diagnostic performance of 40 keV and 70 keV virtual monoenergetic images.", "datePublished": "2024-03-21", "url": "https://questionsmedicales.fr/article/38512626", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11547-024-01806-x" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système nerveux", "item": "https://questionsmedicales.fr/mesh/D009422" }, { "@type": "ListItem", "position": 3, "name": "Maladies neuromusculaires", "item": "https://questionsmedicales.fr/mesh/D009468" }, { "@type": "ListItem", "position": 4, "name": "Maladies de la jonction neuromusculaire", "item": "https://questionsmedicales.fr/mesh/D020511" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Maladies de la jonction neuromusculaire - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Maladies de la jonction neuromusculaire", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Maladies de la jonction neuromusculaire", "description": "Comment diagnostique-t-on une maladie de la jonction neuromusculaire ?\nQuels tests sont utilisés pour évaluer la force musculaire ?\nLes anticorps sont-ils importants dans le diagnostic ?\nQuelle imagerie est utilisée pour ces maladies ?\nLes tests génétiques sont-ils nécessaires ?", "url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Early+Detection+of+Cancer&page=1000#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Maladies de la jonction neuromusculaire", "description": "Quels sont les symptômes courants de ces maladies ?\nLa fatigue musculaire est-elle un symptôme fréquent ?\nLes troubles de la vision peuvent-ils survenir ?\nLes symptômes varient-ils selon l'âge ?\nLes symptômes sont-ils constants ou fluctuants ?", "url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Early+Detection+of+Cancer&page=1000#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Maladies de la jonction neuromusculaire", "description": "Peut-on prévenir les maladies de la jonction neuromusculaire ?\nLes vaccinations peuvent-elles aider ?\nUn mode de vie sain peut-il réduire les risques ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLe stress peut-il aggraver les symptômes ?", "url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Early+Detection+of+Cancer&page=1000#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Maladies de la jonction neuromusculaire", "description": "Quels traitements sont disponibles pour ces maladies ?\nLa plasmaphérèse est-elle utilisée ?\nLes corticostéroïdes sont-ils efficaces ?\nLa rééducation est-elle importante ?\nY a-t-il des traitements expérimentaux ?", "url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Early+Detection+of+Cancer&page=1000#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Maladies de la jonction neuromusculaire", "description": "Quelles sont les complications possibles ?\nLes complications peuvent-elles être graves ?\nComment les complications sont-elles gérées ?\nLes complications affectent-elles la qualité de vie ?\nLes complications peuvent-elles survenir rapidement ?", "url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Early+Detection+of+Cancer&page=1000#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Maladies de la jonction neuromusculaire", "description": "Quels sont les facteurs de risque connus ?\nLe sexe influence-t-il le risque ?\nLes infections peuvent-elles déclencher ces maladies ?\nLe tabagisme est-il un facteur de risque ?\nL'exposition à des toxines est-elle préoccupante ?", "url": "https://questionsmedicales.fr/mesh/D020511?mesh_terms=Early+Detection+of+Cancer&page=1000#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostique-t-on une maladie de la jonction neuromusculaire ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests électromyographiques et des analyses sanguines." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la force musculaire ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de force manuelle et des évaluations fonctionnelles sont réalisés." } }, { "@type": "Question", "name": "Les anticorps sont-ils importants dans le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la détection d'anticorps spécifiques aide à confirmer certaines maladies." } }, { "@type": "Question", "name": "Quelle imagerie est utilisée pour ces maladies ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM peut être utilisée pour évaluer les muscles et détecter des anomalies." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils nécessaires ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être utiles pour identifier des formes héréditaires de la maladie." } }, { "@type": "Question", "name": "Quels sont les symptômes courants de ces maladies ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent faiblesse musculaire, fatigue et difficultés à avaler." } }, { "@type": "Question", "name": "La fatigue musculaire est-elle un symptôme fréquent ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fatigue s'aggrave souvent avec l'activité physique prolongée." } }, { "@type": "Question", "name": "Les troubles de la vision peuvent-ils survenir ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des problèmes oculaires comme la ptose peuvent se manifester." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon l'âge ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'âge d'apparition et la gravité des symptômes peuvent varier." } }, { "@type": "Question", "name": "Les symptômes sont-ils constants ou fluctuants ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent fluctuer, s'aggravant après des efforts ou en fin de journée." } }, { "@type": "Question", "name": "Peut-on prévenir les maladies de la jonction neuromusculaire ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de prévention spécifique, mais un suivi médical régulier est conseillé." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles aider ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne préviennent pas ces maladies, mais protègent contre d'autres infections." } }, { "@type": "Question", "name": "Un mode de vie sain peut-il réduire les risques ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie sain peut améliorer la santé générale, mais ne prévient pas ces maladies." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Certains facteurs environnementaux peuvent influencer le développement de ces maladies." } }, { "@type": "Question", "name": "Le stress peut-il aggraver les symptômes ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress peut exacerber les symptômes et affecter la qualité de vie." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour ces maladies ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments immunosuppresseurs et des thérapies physiques." } }, { "@type": "Question", "name": "La plasmaphérèse est-elle utilisée ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elle peut aider à réduire les symptômes en éliminant les anticorps nocifs." } }, { "@type": "Question", "name": "Les corticostéroïdes sont-ils efficaces ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent améliorer la force musculaire et réduire l'inflammation." } }, { "@type": "Question", "name": "La rééducation est-elle importante ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la rééducation physique aide à maintenir la force et la fonction musculaire." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies géniques et des traitements ciblés sont en cours d'évaluation." } }, { "@type": "Question", "name": "Quelles sont les complications possibles ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des difficultés respiratoires et des infections pulmonaires." } }, { "@type": "Question", "name": "Les complications peuvent-elles être graves ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications peuvent mettre en danger la vie, nécessitant une attention urgente." } }, { "@type": "Question", "name": "Comment les complications sont-elles gérées ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont gérées par des soins médicaux appropriés et un suivi régulier." } }, { "@type": "Question", "name": "Les complications affectent-elles la qualité de vie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent réduire la qualité de vie et nécessiter des adaptations." } }, { "@type": "Question", "name": "Les complications peuvent-elles survenir rapidement ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent se développer rapidement, nécessitant une surveillance étroite." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque connus ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies auto-immunes et l'âge." } }, { "@type": "Question", "name": "Le sexe influence-t-il le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies de la jonction neuromusculaire sont plus fréquentes chez les femmes." } }, { "@type": "Question", "name": "Les infections peuvent-elles déclencher ces maladies ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections virales peuvent précipiter l'apparition de ces maladies." } }, { "@type": "Question", "name": "Le tabagisme est-il un facteur de risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut augmenter le risque de développer des maladies neuromusculaires." } }, { "@type": "Question", "name": "L'exposition à des toxines est-elle préoccupante ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à certaines toxines environnementales peut être un facteur de risque." } } ] } ] }

Sources (10000 au total)

Comparison of breast fine-needle aspiration cytology and tissue sampling for high-throughput proteomic analysis and cancer biomarker detection.

Fine-needle aspiration cytology (FNAC) specimens are widely utilized for the diagnosis and molecular testing of various cancers. We performed a comparative proteomic analysis of three different sample... High-throughput proteomic analysis was conducted on matched FNAC, CNB, and surgical resection tissue samples obtained from breast cancer patients. The protein identification, including currently estab... Compared to tissue samples, FNAC testing revealed a comparable number of proteins (7,179 in FNAC; 7,196 in CNB; 7,190 in resection samples). Around 85% of proteins were mutually identified in all samp... FNAC is suitable for high-throughput proteomic analysis, in addition to an emerging source that could be used to identify and quantify novel cancer biomarkers....

The Impact of Prostate Volume on Prostate Cancer Detection: Comparing Magnetic Resonance Imaging with Transrectal Ultrasound in Biopsy-naïve Men.

This study aimed to determine the difference in prostate volume (PV) derived from transrectal ultrasound (TRUS) and multiparametric magnetic resonance imaging (mpMRI), and to further investigate the r... Patients who underwent an initial prostate biopsy within 3 mo after mpMRI between January 2016 and December 2021 were analyzed retrospectively. The sensitivity, specificity, positive predictive value ... The median prostate-specific antigen level of 875 patients was 9.79 (interquartile range [IQR]: 7.09-13.50) ng/ml. The median mpMRI-PV and TRUS-PV were 41.92 (IQR: 29.29-60.73) and 41.04 (IQR: 29.24-5... TRUS-PV and MRI-PV exhibited a strong linear correlation and reached sufficient agreement. The efficiency of TRUS-PSAD and mpMRI-PSAD for PCa detection was comparable. TRUS could be used for PV estima... In this work, prostate volume (PV) derived from transrectal ultrasound (TRUS) exhibited a strong linear correlation with the PV derived from multiparametric magnetic resonance imaging (mpMRI). The eff...

Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study.

This study aimed to assess the diagnostic value of human epididymal protein 4 (HE4), a potential novel biomarker for lung cancer, and its combined detection with five other conventional biomarkers in ... In this retrospective study, 115 lung cancer patients, 50 patients with benign pulmonary disease, and 50 healthy controls were included. Serum HE4, progastrin-releasing peptide (ProGRP), squamous cell... All six biomarkers showed significantly elevated levels in the lung cancer group compared to both benign pulmonary disease and control groups (... HE4 and its combined detection held substantial clinical significance in the diagnosis of lung cancer and its histologic subtyping, especially for lung adenocarcinoma and lung squamous cell carcinoma....

Pancreatic cancer detection with dual-energy CT: diagnostic performance of 40 keV and 70 keV virtual monoenergetic images.

To compare the diagnostic performance of 40 keV and 70 keV virtual monoenergetic images (VMIs) generated from dual-energy CT in the detection of pancreatic cancer.... This retrospective study included patients who underwent pancreatic protocol dual-energy CT from January 2019 to August 2022. Four radiologists (1-11 years of experience), who were blinded to the fina... Overall, 137 patients (median age, 71 years; interquartile range, 63-78 years; 77 men) were included. Among them, 62 patients (45%) had pathologically proven pancreatic cancer. The 40 keV VMIs had hig... The 40 keV VMIs showed better diagnostic performance in diagnosing pancreatic cancer than the 70 keV VMIs, along with higher reader confidence....

Low-abundance proteins-based label-free SERS approach for high precision detection of liver cancer with different stages.

Surface-enhanced Raman scattering (SERS) technology have unique advantages of rapid, simple, and highly sensitive in the detection of serum, it can be used for the detection of liver cancer. However, ... Serum samples were collected from 60 patients with liver cancer (27 patients with stage T1 and T2 liver cancer, 33 patients with stage T3 and T4 liver cancer) and 40 healthy volunteers. Herein, immuno... The experimental results show that the serum LAPs SERS detection combined with multivariate statistical algorithms can be used for effectively distinguishing liver cancer patients from healthy volunte...

Cerebrospinal fluid circulating tumor DNA contributes to the detection and characterization of leptomeningeal metastasis in non-small cell lung cancer.

Cerebrospinal fluid (CSF) has revealed the unique genetic characteristics of leptomeningeal metastasis (LM) from non-small cell lung cancer (NSCLC). However, the research in this area is still very li... Patients with LM from NSCLC (n = 80) were retrospectively analyzed. Circulating tumor DNA (ctDNA) in CSF was tested by next-generation sequencing (NGS), with paired extracranial tissue or plasma sampl... An overwhelming 93.8% of patients carried druggable mutations in NSCLC LM, with EGFR (78.8%) being the most prevalent. Notably, 4 patients who tested negative for driver genes in extracranial samples ... CSF-based ctDNA analysis is crucial for detecting and characterizing genetic alterations in NSCLC LM. The distinct genetic profiles in CSF and extracranial tissues emphasize the need for personalized ...